arc (Press, personal communication [15] ). These la determinants are controlled by genes in the ! region of the major histocompatibility complex (H-2) (16) . Loci that control immune responses (It) to a variety of antigens also map in the I region and thus are closely linked (or identical) with the loci that control B-cell la determinants (16, 17) .
The T-cell surface markers have been used both to isolate T cells with different functions and to identify the roles that these cells play in the immune response (I-8). For example, in studies on the mechanism of allotype suppression, the difference in Ly phenotypes between Ts and Th was crucial for showing that Ts are different from Th, and that Ts suppress production of antibodies carrying the Ig-lb allotype by removing Th activity capable of helping !g-lb memory B cells (5) .
Using allotype Ts, we have now characterized a new set of T-cell surface determinants (15, 18) which, like Ly, distinguish between Th and Ts populations. Unlike Ly, however, these new T-cell surface determinants are ceded for by loci in the I region of the H-2 complex. Their selective expression on Ts or Th suggests they may be directly related to the immunoregulatory functions associated with this chromosomal region.
The presence of/-region determinants on mouse peripheral T cells was first detected by serologic studies (14, 19) . Later, functional studies showed that anti-I-region antisera blocked antigenic stimulation of T cells (20) , and that cytotoxic treatment with I-region antisera kills the T cells which suppress idiotype (21) or allotype (15, 18) production. In addition, I-region incompatible T cells have been shown to stimulate mixed lymphocyte reactions (22) . /-region antisera have also been shown to both block the binding of antigen-antibody complexes to the Fc receptors on a substantial proportion ofFcR + T cells (15) and to kill the T cells which initiate (promote) the overall T-cell response to concanavalin A (Con A) (23) . Soluble T-cell factors with helper (24, 25) or suppressor (26, 27) activities have also been shown to carry I-region determinants.
In this publication, we will show that Ts and Th carry I-region determinants. We will also show that different antisera kill Th or Ts, and thus, that each of these cell types selectively express determinants that identify functional T-cell subpopulations. In an accompanying publication, we will show that the Ts determinants are different from the B-cell I-region (la) determinants and are controlled by a new locus, la-4, which maps in a previously undefined segment of the I-region provisionally designated the l-J subregion (28) .
Materials and Methods

Mice. (BALB/cNHZ x SJL/JHz)F1 hybrids (Ig~/Ig b, H-2't/H-2 ")
and BALB/cNHz mice were used for the suppression assay and helper assay experiments reported here. Strains used to prepare anti-Ia sera and for absorption studies were BIO/Sn(H-2O), BIO Antigens. Keyhole limpet hemocyanin (KLH) (Pacific Biomarine Supply Company, Venice,
Calif. was dialyzed 24 h against 0.15 M NaC1 and then centrifuged at 10,000 rpm to remove precipitated protein. The resulting supernate was then centrifuged at 30,000 rpm in a fixed-angle rotor for 2 h to pellet the protein, and the pellet was resuspended in 0.01 M cacodylate buffer, pH 6.8. DNPs-KLH (per 10 ' daltons) was prepared by reacting dinitrofiuorobenzene in 40-fold molar excess with the carrier protein for 3 h at pH 8.2 in 0.5 M NaHCO.~ buffer (30) . Free 2,4-dinitrophenol (DNP) was removed by extensively dialyzing the conjugates against phosphatebuffered saline (0.01 M phosphate, pH 7.1, in 0.15 M NaC1).
Donors for Cell Transfer Experiments.
Nonsuppressed donors in adoptive cell transfers were obtained from matings between SJL/JHz males and BALB/cNHz females. Suppressed donors were obtained from matings between SJL/JHz males and BALB/cNHz females immunized against the paternal Ig-lb allotype (9) . Suppressed mice were 6-12-mo old when used and had no detectable serum Ig-lb at time of transfer. To purify T cells from these spleen cells, the nylon wool column method was used (31) .
Priming. DNP-KLH-primed mice received 100 tLg DNP-KLH on alum plus 2 × 10 ~ heat-killed Bordetella pertussis (kindly supplied by Lederle Laboratories, Division of American Cyanamid Company, Pearl River, N. Y.) at least 8 wk before use as donors in adoptive transfer. Spleen cells from these mice were used as a combined source of hapten-primed B cells and carrier-primed T cells or (after depletion of T cells as described below) as a source of hapten-primed B cells.
KLH (carrier)-primed mice received 100 t~g KLH on alum plus 2 × 10 ~" Bordetella pertussis 7 days before use as donors in adoptive transfer. Nylon wool column purified spleen cells were transferred to provide a source of carrier-primed T cells when required.
Depletion of T Cells from Spleen Cell Suspensions. T cells were depleted from spleen cell
suspensions by killing with anti-Thy-1 plus complement in a '~two-step" killing protocol. Cells were incubated with congenic anti-Thy-1.2 (kindly supplied by Doctors E. A. Boyse and F-W Shen at Sloan Kettering Institute for Cancer Research, New York) for 30 rain at 37°C. After the first step, cells were resuspended and incubated with rabbit complement for 30 min at 37°C. After the second step, cells were resuspended and washed once before transfer.
Adoptive Secondary Response to DNP-KLH. Donor cells were injected i.v. into semisyngeneic BALB/c recipients irradiated (600 R) 18-24 h before transfer.
Recipients were challenged i.v. with 10 t~g aqueous DNP-KLH immediately after transfer. 7 days later, recipients were killed, their spleens removed, and DNP-PFC estimated as described below. Since very little (<30%) variability in spleen size, cell yield, or response is usually found between individuals in the same group, 3-5 recipients were used per group and their spleen cells pooled before plaquing (5, 11, 32) .
Estimation of DNP-PFC in Recipient
Spleen. The PFC assay described by Cunningham and Szenberg was used to estimate the number of cells secreting anti-DNP antibody (33) .
Samples of individual or pooled spleen cell suspensions to be tested were mixed with trinitrophenyl-coated burro erythrocytes (34) , frozen and reconstituted guinea pig serum (complement), and developing antisera (when desired). Chambers were incubated at 37°C for 1 h and the number of DNP-PFC counted with the aid of a dissecting microscope. Counts from a minimum of two chambers were averaged for each determination. The response is expressed as PFC/106 recipient spleen cells. The number of indirect PFC was determined by subtracting direct PFC/106 (no developing antiserum) from the total PFC/106 found when developing antiserum was included in the chamber. In general, the direct PFC response is less than 20% of the total IgG response.
Antisera for PFC Assay. Total IgG PFC were developed with a rabbit antiserum reactive with all IgG classes. Specific anti-allotype antisera were used to develop Ig-la and Ig-lb PFC. Heteroantisera detecting Ig-la and Ig-lb were rendered specific by appropriate absorptions with insoluble immunoabsorbents (5, 11) . The starting serum for anti-Ig-la was produced by immunizing a goat with the Ig-la myeloma protein 5563. The starting serum for the anti-Ig-lb was produced by immunizing a rabbit with C75BL/6 (Ig °) globulins. (This serum was kindly supplied by Dr. John Coe, Rocky Mountain National Laboratory.) All sera were tested for specificity by radioimmune assays and plaque development.
Preparation and Absorption ofAnti-Ia Sera. Mice were immunized i.p. with a suspension of spleen and lymph node cells (approximately 1.5 × 107 cells/mouse). The mice were boosted on days 28, 35, and 42, and bled on days 49 and 51. Thereafter, animals were reimmunized every 3rd wk and bled 7 and 9 days after each booster injection.
In vitro absorption of antiserum was performed as follows: 1.0 ml of antiserum, diluted 1:5, was added to a pellet comprised of spleen and lymph node cells from four mice and incubated for 1 h at room temperature. In vivo absorption was done by injecting 0.3 ml of undiluted antiserum i.p. and bleeding 3-4 h later. Table I shows the specificity of antisera used in this study.
Cytotoxic Treatment by Anti-Ia. Cytotoxic treatment was done in a "two-step" killing protocol.
Cell suspensions were incubated with appropriately diluted anti-Ia for 30 min at 37°C (1-2 × 107 cells/ml). Cells were centrifuged and resuspended in media containing rabbit complement diluted 1:12 and incubated for 40 min at 37°C. After passing through a fetal calf serum gradient, the cells were used for transfer experiments.
Results Ts activity is assayed by the ability to suppress specifically an adoptive secondary Ig-lb allotype DNP-PFC response by cotransferred DNP-KLHprimed, syngeneic, nonsuppressed spleen cells. Nonsuppressed prime DNP-KLH spleen cells from the allotype heterozygous (Ig~/Ig b) (BALB/c x SJL)F1 hybrid mice used in these studies give rise to approximately equal numbers of Ig-la and Ig-lb DNP-PFC when transferred without Ts in an adoptive secondary assay. Ts reduce the Ig-lb response without affecting the Ig-la or other IgG responses. Therefore, suppression is usually evaluated by comparison of the Iglb and Ig-la responses in a given group of adoptive secondary recipients. In the experiments presented below, the Ts dose (number of suppressed spleen cells) used is just slightly greater than the number required to completely suppress the Ig-lb response by the primed nonsuppressed cells (32) .
Suppressor T Cells Carry Surface I-Region Determinants. Data in Table II show that allotype Ts carry surface determinants controlled by genetic loci within the I region. Three/-region sera which kill Ts are shown in this table. One of these antisera, A.TL anti-A.TH, is produced in strains that differ in the I, S, and G regions of the H-2 complex as well as for a segment of the 17th chromosome which lies outside the H-2 complex and includes the Tla locus (Table I ). The other two antisera, (B10.A x A.TL)F1 anti-B10.HTT and (B10.T(6R) x B10.D2)F1 anti-B10.AQR, are made between congenic strains which differ only for determinants controlled by a portion of the I region. The ability of these latter sera to kill Ts places the control of a set of Ts surface determinants clearly within the I region.
Evidence that a fourth/-region antiserum (B10 x HTI)F1 antiB10.A(5R) does not kill Ts is also presented in Table II . This serum (see below) kills helper T cells required for an IgG adoptive secondary response./-region haplotype differ- ences between the strains used to prepare this serum (see Table I ) indicate that it should also contain antibody against the determinants present on Ts. Its failure to kill Ts apparently reflects biological variability in the response to the immunizing Ia antigens. (We have seen similar variability with respect to Th kill, where one pool ofA.TL anti-A.TH kills Th and another does not, although both pools kill Ts.) Data in Table III show that complement is required for removal of Ts activity. This demonstrates that the/-region antisera are killing rather than inactivating (blocking) a cell required for Ts activity. Data in this table also demonstrate that Ts are the direct targets of the/-region antisera cytotoxicity. The ability of /-region antisera to kill nylon column purified spleen Ts cells rules out indirect killing as the result of massive B-cell death; and the failure of anti-Thy-1-treated (T-depleted) spleen cells from suppressed mice to restore the Ts activity removed by cytotoxic treatment of the nylon-purified cells with/-region antisera demonstrates that these antisera are killing the Thy-1 positive cells responsible for suppression, i.e., Ts.
Normal Lymphoid Cells Carry The I-Region Determinants Detected on Allotype Suppressor T Cells. The cytotoxic activity of/-region antisera against (BALB/c x SJL)F, allotype suppressor T cells (Ts) provides clear evidence that the determinants detected are not restricted to these cells, since (a) the lymphoid cells used to raise the antisera came from donor strains which would not be expected to show allotype suppression of the type seen in (BA1B/c x SJL)F, hybrids, and (b) the donors were not given the exposure to anti-allotype antisera required for the induction of allotype Ts. One of the immunizing donor strains (A.TH) does not even carry the Ig-lb allele whose product is suppressed by allotype Ts. Thus, unless allotype Ts are a constituent population in normal lymphoid tissues, the/-region determinants found on allotype Ts are carried by other lymphoid cells as well. The same point is demonstrated by in vivo and in vitro absorption studies with normal nonsuppressed animals. Cytotoxic activity for Ts was completely removed from the three/-region antisera described above by absorption with the immunizing strain or strains carrying the same/-region haplotypes. No activity was removed by absorption with the serum donor strain or strains carrying the same/-region haplotype, thereby demonstrating the specificity of these sera for /-region determinants (18, 28) . In the representative absorption experiment shown in Table IV , (B10.A × A.TL)F1 anti-B10.HTT was absorbed in vitro with spleen cells from B10.A and B10.HTT. B10.A, one of the parental strains in the serum producer, absorbed no cytotoxic activity, while B10.H2~I ~, the immunizing strain, was able to absorb all the activity. The absorptions demonstrate that mouse strains of the appropriate haplotype have lymphoid cells carrying the same determinants found on allotype Ts.
Data presented elsewhere (28) show that the Ts/-region determinants are present on T but not B cells; and data presented here show that at least some of theI-region determinants detected on Ts are not present on helper T cells. Thus, these determinants mark a subset T lymphocytes which, in allotype-suppressed mice, contains the allotype suppressor T cell. Whether the T cells in normal mice which bear the Ts/-region determinants are also suppressor T cells, perhaps generated in response to environmental or self-antigens, remains to be determined.
Helper T Cells Carry I-Region Determinants. Th activity in these studies is measured in a "homologous" adoptive secondary antibody response to DNP. DNP-KLH-primed spleen cells treated with anti-Thy-l.2 plus complement are used as a source of DNP-primed B cells. These cells are cotransferred with Th (KLH-primed spleen cells) untreated or pretreated with/-region antisera plus complement. The Th dose is chosen such that the splenic IgG DNP-PFC response in recipients of untreated Th is proportional to the amount of Th activity injected (i.e., the Th dose limits the response). Donors are (BALB/c x SJL)F, hybrids. Recipients are irradiated (600 R) BALB/c.
Three sera containing/-region antibody were found which kill Th (see Table  V ). One of these sera, (B10.T(6R) x B10.D2)F, anti-B10.AQR, was produced between congenic strains differing only within the I region, indicating that surface determinants detected on Th are controlled by loci within this segment. Furthermore, since the strains used to prepare this serum differ only in the I-A, I-B, and I-J (Table I) subregions, the loci controlling the Th determinants must map to one of these subregions.
Th activity is also removed from carrier-primed nylon-passed T cells by treatment with anti-I-region sera. This suggests that Th killing by these antisera (like Ts killing) is not due to the concomitant death of large numbers of Ia positive B cells (see Table VI ). Data in the same table also show the titration of A.TL anti-A.TH cytotoxic activity for Th, and that removal of Th activity is complement dependent. This Th killing activity is removed from the antisera by in vivo absorption with normal (unprimed) animals of the appropriate haplotype (18) .
In both of these experiments, as in all other Th removal experiments, DNP-KLH-primed B cells treated with congenic anti-Thy-1 to remove endogenous Thy-i positive helper cells were used as the source of hapten-primed B cells. These Thy-l-depleted spleen cell populations should supply all other types of cells required for the adoptive secondary response. Therefore, the removal of Th activity by I-region antisera demonstrates that these sera kill the Thy-1 positive cells which help IgG responses, i.e., helper T cells. The removal of Th activity by the I-region antisera used here is considerably less effective than the removal of Ts. To detect a loss of Th activity, the Th assay had to be optimally sensitive, i.e., the Th dose used had to limit the response. We have shown in other studies (unpublished) that even a twofold excess of Th activity virtually obscures the measurable reduction of Th activity due to cytotoxic treatment of the Th with I-region antisera. This is consistent with evidence that shows that Th killing by these antisera is incomplete under the conditions we use (see Table V ).
TABLE VI
Titration of I-Region Sera for Removal of Helper T-Cell Activity
Reports by H~immerling et al. (21) and Press (in reference 15) have appeared indicating that I-region antisera do not kill Th. Differences in antisera, mouse strains, or assay conditions could account for the discrepancy between these results and ours. In particular, we measure helper activity by transfer of F1 hybrid cells into one of the parental strains (BALB/c). Although the recipient is sufficiently irradiated (600 R) so that the graft survives indefinitely in over 95% of recipients, there appears to be an incompatibility Cback-stimulation") reaction which increases the PFC response approximately two to threefold over that obtained by transfer in syngeneic hybrid recipients (Herzenberg, unpublished observation). This augmentation is not due to T-cell replacement due to an allogeneic effect since primed helper cells are required to obtain a DNP-PFC response in this transfer system. The augmentation may, however, be important in allowing the demonstration of Th removal by I-region antisera.
The reduction in Th activity reported here could in fact be due to interference with the augmentation mechanism rather than to direct removal of Th, i.e., the residual Th activity we observe after treatment withI-region sera could actually be the Th activity measurable under nonaugmentation conditions. The consistent removal of 80% or more of the Th activity observed after antiserum treatment argues against this possibility, since the residual Th activity appears to be significantly less than would be expected in the absence of augmentation. Work is in progress to conclusively resolve this problem. At present, it is not clear whether the type of Th activity removed is demonstrable only in the adoptive transfer assay used in our studies or also can be identified in the usual syngeneic transfer system.
Selective Expression of Determinants on Helper and Suppressor T Cells.
We have shown in the preceding sections that one of the antisera which kills Ts, (B10.A x A.TL)F, anti-B10.HTT, does not kill Th (see Tables III and V) . This demonstrates that Ts carry/-region determinants not found on Th.
Our studies also show that Th carry determinants not found on Ts, since one of the antisera which kills Th, (B10 x HTI)F1 anti-B10.A(SR), does not kill Ts. This antiserum, however, is produced in strains that differ not only in the I region, but also in the S and possibly G regions of the H-2 complex (see Table I ). Thus, we cannot conclude that the Th determinants it detects are definitely controlled within the I region. Data with another antiserum, (B10.T(6R) x B10.D2)F1 anti-B10.AQR, demonstrate clearly that Th do carry I-region determinants (see Table V ). This antiserum, however, also kills Ts, and therefore, could be detecting the same I-region determinants on Ts and Th. Nevertheless, the most economical interpretation of the data obtained with these two antisera suggests that Th carry/-region determinants which are not present on Ts.
Discussion
The detection of I-region determinants on Th and Ts provides a new tool for studying the cellular interactions which regulate immune responses. It also provides some interesting new insights into the role of the/-region itself in immunoregulation.
We have shown elsewhere that the/-region determinants on Ts are controlled by a locus, Ia-4, separable by crossing over from the loci which control/-region (Ia) determinants on B cells (28) . This locus marks a new subregion,/-J, located between the I-B and I-C subregions. It also contains loci (possibly the same as Ia-4) which code for determinants on the T cells which initiate (promote) Con A responsiveness (Frelinger, personal communication) and for determinants on the T cells and soluble factors which suppress antibody responses dependent on KLH for carrier function (27) .
Ia-4 determinants do not appear to be restricted to allotype Ts, since spleen cells from nonsuppressed mice were used both to generate and to absorb the anti-Ia-4 antibody. Nevertheless, these determinants are restricted to a subpopulation ofT lymphocytes. Absorption studies presented elsewhere (28) show that B cells do not carry Ia-4 determinants although T cells do; and data presented here show that Ts, but not Th, carry Ia..4. (If Ts and Th carry shared/-region determinants these would have to be controlled by a separate locus, assuming one locus per gene product.) Thus Ia-4 determinants are carried on a subset of T lymphocytes, including allotype Ts.
Th also carry H-2-controlled determinants restricted to a subset of T lymphocytes. As we have shown here, an antiserum that kills Th does not kill Ts; therefore, the Th determinants define a T-cell subset which does not include Ts. Whether these determinants on Th are controlled by the I, S, or G subregions and whether they are different from the Ia determinants on B cells remains to be determined. The evidence that Th definitely carry/-region determinants suggests that the locus that controls the unique Th determinants are in the/-region.
The Ly surface antigens also identify distinct T-cell subsets containing Ts (Ly-2) or Th (Ly-1); however, the Ly-2 subset apparently contains more functionally identifiable cells than those contained within the Ia-4-bearing subset. This subdivision of Ly-2 cells into Ia-4 positive or negative bears on the question of whether Ts are cytotoxic T cells. Cytotoxic precursor and effector cells, like allotype Ts, are Ly-2 (2); however, in contrast to allotype Ts, cytotoxic precursors and effector cells do not appear to carry/-region surface determinants (21) . If the same pools ofI-J antisera used here to kill Ts fail to kill (BALB/c × SJL)F~ cytotoxic cells, then evidence for a subdivision of Ly-2 cells will be complete. As a corollary, this would demonstrate that the mechanism of allotype suppression, i.e., allotype Ts removal of Th activity (Ig-lb Th) which helps Ig-lb memory B cells (5, 32) , does not involve killing by cytotoxic T cells such as those responsible for cellular immunity (36) .
Other evidence also suggests that removal ofIg-lb Th activity by Ts is not due to cytotoxic killer cells. Cultured spleen cells from allotype-suppressed mice produce a soluble suppressive factor (TsF) which specifically removes Ig-lb helper activity. Carrier-primed spleen cells cultured for 24 h in the presence of TsF lose virtully all Ig-lb Th activity detectable in the adoptive transfer assay although other Th activity is unaffected (5) . Serum from suppressed mice also contains TsF activity (unpublished observation). Thus allotype suppression appears to be mediated, at least in part, by TsF. Cytotoxic killer cells, in contrast, appear to kill by direct cell-to-cell contact (26) .
The presence of/-region determinants on Th and Ts provides a different framework for consideration of the mechanism of suppression. The location of the loci coding for these determinants in close proximity to the Ir loci which control immune responsiveness to a variety of antigens suggests that the Ts and Th determinants may in general play a role in immunoregulation. This thesis is considerably strengthened by the demonstration that soluble factors, which mediate suppression (26) or help (15, 24, 25) , carryI-region determinants and by evidence that specific immune suppression (Is) genes map in the/-region (37, 38) . Although the evidence is still too fragmentary to allow clear definition of the role of these determinants, the existing data are consistent with their being part of the regulatory language used for communication among responding lymphocytes.
For example, in allotype suppression three cells make up a basic network: Iglb memory cells which give rise to Ig-lb afc, Ig-lb Th which are required for the differentiation and expansion of Ig-lb memory cells to afc, and Ig-1 b Ts which remove Ig-lb Th activity (5). How Ig-lb allotype Ts recognize the Ig-lb Th is unknown; however, as indicated above, Ig-lb Th activity can be removed from carrier-primed spleen cells by pretreatment with a TsF produced by Ts containing spleen cells. At least one of the cells in this network (Ts) is marked by unique/-region determinants. The other two cells (Th and B) carry/-region determinants which may (or may not) be shared; however, Th carry H-2-controlled determinants (probably/-region) which are not present on Ts.
Tada has described what may be a similar network regulating antibody responses to KLH and haptens coupled to KLH. These studies directly implicate I-J subregion determinants (not necessarily Ia-4) in what appears to be a TsFmediated interaction between Ts and Th. Tada and co-workers have shown (a) that KLH-specific Ts carry surface I-J determinants (personal communication); (b) that soluble suppressive factors (KLH-TsF) extracted from Ts-containing thymus or spleen also carry I-J determinants (27) ; and (c) that effective suppression with KLH-TsF requires the presence of I-region-encoded receptors for KLHTsF on the responding (target) strain T (but not B) cells (39) . Tada has not yet directly determined whether KLH-TsF removes Th activity. We have not yet determined whether allotype TsF carries I-J determinants. But the similarities between the two systems suggest that at this point the information gathered should be integrated for consideration of overall mechanisms of regulation of antibody production. The results of such "integration" suggest to us that Ts produce soluble factors which kill or inactivate Th; and that I-J determinants on the soluble factors are involved in the recognition (removal) of the target Th. Thus the selective expression of I-region determinants on cells and factors involved in antibody production appears to be an integral part of the mechanism for regulation of this process. Summary Data presented here show that loci in the/-region of the H-2 gene complex are selectively expressed in different functional T-cell subpopulations. These loci are closely linked (or possibly identical) to loci that control immune responses. They control surface determinants which identify helper and suppressor T lymphocytes.
Determinants described here on allotype suppressor T cells (Ts) are found on normal (nonsuppressed) lymphoid cells, but are not found on helper T cells (Th). These determinants are controlled by a locus mapping in the I region of the H-2 complex. In an accompanying publication we show that this locus (Ia-4) marks a new I subregion (I-J) and is expressed only on T cells. Thus Ia-4 determinants identify a T-cell subpopulation which includes Ts but not Th.
Th also carry identifying surface determinants controlled by loci that map to the H-2 complex, probably within the I region. These determinants are not found on Ts. Data presented also establish that loci in the I region control determinants on Th, but do not conclusively demonstrate that these are the determinants that distinguish Th from Ts.
The selective expression of H-2-controlled determinants on Ts and Th suggests that these determinants are directly involved in immunoregulation.
